Literature DB >> 28142201

Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation.

B Dedeoglu1, A E de Weerd1, L Huang1, A W Langerak2, F J Dor3, M Klepper1, W Verschoor1, D Reijerkerk1, C C Baan1, N H R Litjens1, M G H Betjes1.   

Abstract

Ageing is associated with changes in the peripheral T cell immune system, which can be influenced significantly by latent cytomegalovirus (CMV) infection. To what extent changes in circulating T cell populations correlate with T cell composition of the lymph node (LN) is unclear, but is crucial for a comprehensive understanding of the T cell system. T cells from peripheral blood (PB) and LN of end-stage renal disease patients were analysed for frequency of recent thymic emigrants using CD31 expression and T cell receptor excision circle content, relative telomere length and expression of differentiation markers. Compared with PB, LN contained relatively more CD4+ than CD8+ T cells (P < 0·001). The percentage of naive and central memory CD4+ and CD8+ T cells and thymic output parameters showed a strong linear correlation between PB and LN. Highly differentiated CD28null T cells, being CD27- , CD57+ or programmed death 1 (PD-1+ ), were found almost exclusively in the circulation but not in LN. An age-related decline in naive CD4+ and CD8+ T cell frequency was observed (P = 0·035 and P = 0·002, respectively) within LN, concomitant with an increase in central memory CD8+ T cells (P = 0·033). Latent CMV infection increased dramatically the frequency of circulating terminally differentiated T cells, but did not alter T cell composition and ageing parameters of LN significantly. Overall T cell composition and measures of thymic function in PB and LN are correlated strongly. However, highly differentiated CD28null T cells, which may comprise a large part of circulating T cells in CMV-seropositive individuals, are found almost exclusively within the circulation.
© 2017 British Society for Immunology.

Entities:  

Keywords:  T cells; ageing; end-stage renal disease; lymph node; peripheral blood

Mesh:

Substances:

Year:  2017        PMID: 28142201      PMCID: PMC5383449          DOI: 10.1111/cei.12934

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

Review 1.  A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients.

Authors:  Michiel G H Betjes; Ruud W J Meijers; Lucia E A de Wit; Nicolle H R Litjens
Journal:  J Nephrol       Date:  2012 Mar-Apr       Impact factor: 3.902

Review 2.  Fractalkine/CX3CL1: a potential new target for inflammatory diseases.

Authors:  Brian A Jones; Maria Beamer; Salahuddin Ahmed
Journal:  Mol Interv       Date:  2010-10

3.  Human naive and memory T lymphocytes differ in telomeric length and replicative potential.

Authors:  N P Weng; B L Levine; C H June; R J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

4.  Long time follow up of CD28- CD4+ T cells in living kidney transplant patients.

Authors:  M Kato; Y Ono; T Kinukawa; R Hattori; O Kamihira; S Ohshima
Journal:  Clin Transplant       Date:  2004-06       Impact factor: 2.863

5.  Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.

Authors:  Ester M M van Leeuwen; Ester B M Remmerswaal; Mireille T M Vossen; Ajda T Rowshani; Pauline M E Wertheim-van Dillen; René A W van Lier; Ineke J M ten Berge
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

Review 6.  Biology of immune responses to vaccines in elderly persons.

Authors:  Birgit Weinberger; Dietmar Herndler-Brandstetter; Angelika Schwanninger; Daniela Weiskopf; Beatrix Grubeck-Loebenstein
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

7.  Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues.

Authors:  Joseph J C Thome; Kara L Bickham; Yoshiaki Ohmura; Masaru Kubota; Nobuhide Matsuoka; Claire Gordon; Tomer Granot; Adam Griesemer; Harvey Lerner; Tomoaki Kato; Donna L Farber
Journal:  Nat Med       Date:  2015-12-14       Impact factor: 53.440

8.  Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.

Authors:  Elisabeth Amyes; Chris Hatton; Damien Montamat-Sicotte; Nancy Gudgeon; Alan B Rickinson; Andrew J McMichael; Margaret F C Callan
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

9.  Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people.

Authors:  Sven Koch; Anis Larbi; Evelyna Derhovanessian; Dennis Ozcelik; Elissaveta Naumova; Graham Pawelec
Journal:  Immun Ageing       Date:  2008-07-25       Impact factor: 6.400

10.  Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation.

Authors:  Michiel G H Betjes; Willem Weimar; Nicolle H R Litjens
Journal:  J Transplant       Date:  2013-10-01
View more
  12 in total

1.  Co-inhibitory profile and cytotoxicity of CD57+ PD-1- T cells in end-stage renal disease patients.

Authors:  R Kraaijeveld; G N de Graav; M Dieterich; N H R Litjens; D A Hesselink; C C Baan
Journal:  Clin Exp Immunol       Date:  2017-11-09       Impact factor: 4.330

Review 2.  Stress and immunosenescence: The role of telomerase.

Authors:  Karin de Punder; Christine Heim; Pathik D Wadhwa; Sonja Entringer
Journal:  Psychoneuroendocrinology       Date:  2018-10-23       Impact factor: 4.905

3.  Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients.

Authors:  Joanna Schaenman; Korntip Phonphok; Ittikorn Spanuchart; Tin Duong; Theodore M Sievers; Erik Lum; Elaine F Reed; Suphamai Bunnapradist
Journal:  Transpl Infect Dis       Date:  2020-09-22       Impact factor: 2.228

4.  Human immunology studies using organ donors: Impact of clinical variations on immune parameters in tissues and circulation.

Authors:  D J Carpenter; T Granot; N Matsuoka; T Senda; B V Kumar; J J C Thome; C L Gordon; M Miron; J Weiner; T Connors; H Lerner; A Friedman; T Kato; A D Griesemer; D L Farber
Journal:  Am J Transplant       Date:  2017-09-08       Impact factor: 9.369

5.  T-Cell Composition of the Lymph Node Is Associated with the Risk for Early Rejection after Renal Transplantation.

Authors:  Burç Dedeoglu; Nicolle H R Litjens; Annelies E de Weerd; Frank Jmf Dor; Mariska Klepper; Derek Reijerkerk; Carla C Baan; Michiel G H Betjes
Journal:  Front Immunol       Date:  2017-10-27       Impact factor: 7.561

6.  High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.

Authors:  Michiel G H Betjes; Nicolle H R Litjens
Journal:  PLoS One       Date:  2020-02-05       Impact factor: 3.240

7.  Increased circulating Tfh to Tfr ratio in chronic renal allograft dysfunction: a pilot study.

Authors:  Lin Yan; Yamei Li; Yi Li; Xiaojuan Wu; Xianding Wang; Lanlan Wang; Yunying Shi; Jiangtao Tang
Journal:  BMC Immunol       Date:  2019-08-05       Impact factor: 3.615

Review 8.  Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses.

Authors:  Michiel Gh Betjes
Journal:  Toxins (Basel)       Date:  2020-04-03       Impact factor: 4.546

9.  A very low thymus function identifies patients with substantial increased risk for long-term mortality after kidney transplantation.

Authors:  Michiel G H Betjes; Anton W Langerak; Mariska Klepper; Nicolle H R Litjens
Journal:  Immun Ageing       Date:  2020-02-13       Impact factor: 6.400

10.  The Frailty Risk Score predicts length of stay and need for rehospitalization after kidney transplantation in a retrospective cohort: a pilot study.

Authors:  Joanna Schaenman; Loren Castellon; Emily C Liang; Deepa Nanayakkara; Basmah Abdalla; Catherine Sarkisian; Deena Goldwater
Journal:  Pilot Feasibility Stud       Date:  2019-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.